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ABSTRACT 19 
 20 
Genetic inactivation of the epithelial Na+ channel α-subunit (αENaC) in the renal 21 
collecting duct (CD) does not interfere with Na+ and K+ homeostasis in mice. 22 
However, inactivation in the CD and a part of the connecting tubule (CNT) induces 23 
autosomal recessive pseudohypoaldosteronism type 1 (PHA-1) symptoms already on 24 
a standard diet. In the present study, we further examined the importance of αENaC 25 
in the CNT. Knock-out mice with αENaC deleted primarily in a part of the CNT (CNT-26 
KO) were generated using Scnn1alox/lox mice and Atp6v1b1::Cre mice. On a standard 27 
diet, plasma [Na+] and [K+], and urine Na+ and K+ output were unaffected. Seven days 28 
of Na+ restriction (0.01% Na+) led to a higher urine Na+ output only on day 3–5, and 29 
after 7 days plasma [Na+] and [K+] were unaffected. By contrast, the CNT-KO mice 30 
were highly susceptible to a 2-day 5% K+ diet and showed lower food intake and 31 
relative body weight, lower plasma [Na+], higher fractional excretion (FE) of Na+, 32 
higher plasma [K+], and lower FE of K+. The higher FE of Na+ coincided with lower 33 
abundance and phosphorylation of the Na+-Cl- cotransporter, NCC. In conclusion, 34 
reducing ENaC expression in CNT induces clear PHA-1 symptoms during high dietary 35 
K+ loading. 36 
 37 
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INTRODUCTION 42 
 43 
The functional epithelial Na+ channel (ENaC) consists of the 3 homologous subunits, 44 
α-, β-, and γ (3). Renal ENaC mediates Na+ reabsorption across the apical plasma 45 
membrane of late distal convoluted tubule (DCT2) cells, connecting tubule (CNT) 46 
cells, and collecting duct (CD) principal cells (17). Furthermore, ENaC-facilitated K+ 47 
secretion through apical K+ channels in the CNT and the cortical CD (CCD) may be 48 
crucial for maintaining K+ homeostasis (10). During conditions of hypotension and 49 
hyperkalemia, high angiotensin II or K+ plasma levels stimulate adrenal glomerulosa 50 
cells to release the steroid hormone, aldosterone (33). The DCT2/early CNT are 51 
largely insensitive to aldosterone, which is in contrast to the late CNT/CCD, where 52 
ENaC activity is markedly increased by aldosterone (18, 23). 53 
 Loss-of-function mutations in any ENaC subunit may lead to the life-threatening 54 
disease, autosomal recessive pseudohypoaldosteronism type 1 (PHA-1). PHA-1 is 55 
characterized by, e.g., hyponatremia and hyperkalemia due to impaired ability of the 56 
kidney to reabsorb Na+ and excrete K+ (4). We have in previous studies generated 57 
various αENaC knock-out (KO) mouse lines contributing to an improved 58 
understanding of the PHA-1 disease and the physiological importance of the ENaC 59 
complex. Global αENaC inactivation is highly critical, leading to neonatal death (12). 60 
Inactivation of αENaC in the CD and a part of the CNT (CNT/CD-KO) induces mild 61 
hyponatremia on a standard diet and in addition serious weight loss during Na+ 62 
restriction (5). By contrast, CD-specific αENaC KO (CD-KO) mice are unaffected both 63 
during Na+ restriction and high dietary K+ loading (28). Finally, conditional 64 
inactivation of αENaC in the colon (colon-KO) induces fecal Na+ wasting but this is 65 
compensated by the kidney and Na+ homeostasis is therefore not impaired (19). 66 
Hence, these studies collectively point towards a critical role of αENaC particularly in 67 
the DCT2 and CNT.  68 
 In the present study, we further examined the importance of αENaC in the CNT. 69 
KO mice with αENaC deleted primarily in the CNT (CNT-KO) were generated using 70 
Scnn1alox/lox mice (13) and Atp6v1b1::Cre mice. The latter mice have previously been 71 
shown to express Cre recombinase in intercalated cells and in approximately 50% of 72 
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the CNT cells (20). This correlates with weak V-ATPase B1-subunit expression in 73 
some CNT cells (1, 21). We performed a thorough characterization of the 74 
Atp6v1b1::Cre mouse line by crossing it with an enhanced green fluorescent protein 75 
(EGFP) reporter mouse line. The CNT-KO mice and the control littermates were 76 
examined on standard and challenging diets.  77 
 78 
METHODS 79 
 80 
Breeding of CNT-KO mice and control littermates, and Cre/EGFP reporter mice 81 
 82 
 The Cre/loxP recombination system was utilized to investigate the role of ENaC 83 
in the CNT for Na+ and K+ balance. We used a transgenic mouse line (genetic 84 
background: C57BL/6J) in which exon 1 of the gene encoding the α-subunit of ENaC 85 
(Scnn1a) was flanked by loxP sites [Scnn1alox/lox (13)]. The Scnn1alox/lox mouse line 86 
was crossed with a mouse line (genetic background: C57Bl6/CBA) expressing Cre 87 
recombinase under the regulatory elements of the Atp6v1b1 gene (Atp6v1b1::Cre) 88 
encoding the V-ATPase B1-subunit (20). The Atp6v1b1::Cre mouse line was also 89 
recently utilized to inactivate aquaporin-2 genetically in the CNT (16). Interbreeding 90 
of Scnn1alox/lox and heterozygous Atp6v1b1::Cre mice generated Scnn1alox/+; 91 
Atp6v1b1::Cre mice, which were further crossed to generate Scnn1alox/lox; 92 
Atp6v1b1::Cre mice. Finally, the Scnn1alox/lox; Atp6v1b1::Cre mice were crossed with 93 
Scnn1alox/lox mice to generate CNT-KO mice (Scnn1alox/lox; Atp6v1b1::Cre) and control 94 
littermates (Scnn1alox/lox). The mice were kept on a pelleted mouse chow standard 95 
diet (Altromin Spezialfutter GmbH & Co. KG, Lage, Germany) in regular cages at 20°C. 96 
Genotyping was carried out by running PCR analyses of tail biopsies using the 97 
primers: Scnn1a (forward) 5’-CTC AAT CAG AAG GAC CCT GG-3’, Scnn1a (forward): 98 
5’-GTC ACT GTG TGC ACC CTT AA-3’, and Scnn1a (reverse): 5’-GCA CAA AGA TCT TAT 99 
CCA CC-3’, Cre (forward): 5’-GTT CGC AAG AAC CTG ATG GAC-3’, and Cre (reverse)5’-100 
CTA GAG CCT GTT TTG CAC GTT-3’ (13). 101 
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 In order to examine Cre recombinase activity in the Atp6v1b1::Cre line, these 102 
mice were crossed with a dsRed/Cre-inducible EGFP reporter line [B6.Cg-Tg(CAG-103 
DsRed,-EGFP)5Gae/J; The Jackson Laboratory, Bar Harbor, Maine, USA]. 104 
 105 
Experimental protocols 106 
 107 
 A mixed population of male and female mice was studied [body weight (BW) 108 
CNT-KO mice: 22.9 ± 0.4 g, n = 64; BW control mice: 22.6 ± 0.4 g, n = 60; P = 0.383]. 109 
For metabolic experiments, mice were kept in individual metabolic cages 110 
(Techniplast, Buguggiate, Italy) at 27°C and initially fed a 3-day specialized standard 111 
diet (0.25% Na+/0.7% K+; Altromin Spezialfutter GmbH & Co. KG, Lage, Germany). On 112 
day 3, baseline parameters were recorded (BW, food intake, water intake, and urine 113 
output) after which the mice were put on either a 4-day 0.01% Na+ diet (age: 10-15 114 
weeks; for immunolabeling only), 7-day 0.01% Na+ diet (age: 13–28 weeks, two 115 
experiments pooled), 4-day 2% K+ diet (age: 12–25 weeks), or a 2-day 5% K+ diet 116 
(age: 10–37 weeks; two experiments pooled) or a or a 5% K+/0.01% Na+ diet (age: 5–117 
25 weeks; two experiments pooled). The diets were given as a mixture of food and 118 
water [37.5% water (w/w)]. The added water was included in the total water intake. 119 
For experiments in regular cages (blood sampled on standard diet; two experiments 120 
were pooled for aldosterone measurements), mice were kept in individual cages at 121 
20°C and fed a pelleted mouse chow diet for 7 days (Altromin Spezialfutter GmbH & 122 
Co. KG). Mice had free access to food and water for the duration of all experiments. On 123 
the last experimental day, mice were anesthetized by isoflurane inhalation, and blood 124 
and tissue were collected. All experimental protocols complied with the European 125 
Community guidelines for the use of experimental animals and were performed in 126 
agreement with a license issued by the Animal Experiments Inspectorate, Ministry of 127 
Food, Agriculture and Fisheries, Danish Veterinary and Food Administration. 128 
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Collection and analyses of urine and blood 129 
 130 
 Urine was collected in metabolic cages and cleared by centrifugation at 1000 g for 131 
4 min, and concentrations of Na+ and K+ were measured using an IL943TM flame 132 
photometer (Instrumentation Laboratory, Bedford, MA, USA; range Na+ and K+: 0–200 133 
mM; QC: standards). Blood was collected through the portal vein using a 0.6 x 25 mm 134 
needle containing 5 µl Li+ heparin solution and transferred to heparin-coated 135 
centrifuge tubes (PSTTM LH Tubes; BD, Franklin Lakes, NJ, USA) and immediately 136 
centrifuged at 12,000 g for 4 min. Plasma concentrations of Na+ and K+ were 137 
measured by MRC Harwell (Oxfordshire, UK) and determined using an ion selective 138 
electrode (AU680; Beckman Coulter, Brea, CA, USA; range Na+: 50–200 mM; range K+: 139 
1.0–10.0 mM, QC: standards). Plasma aldosterone concentrations were determined 140 
using an enzyme immunoassay kit (EIA-5298; DRG International Inc., Springfield, NJ, 141 
USA; range: 20–1000 pg/ml; QC: standards). Osmolality of urine and plasma was 142 
measured using a freezing point depression osmometer (Advanced® Model 3320 143 
Micro-Osmometer; Advanced Instruments, Inc., Norwood, MA, USA; range: 0–2000 144 
mOsm/kg; QC: standards). Urinary NGAL [neutrophil gelatinase-associated lipocalin; 145 
a biomarker for acute kidney injury (AKI) (7, 15)] concentrations were measured 146 
using a mouse NGAL ELISA kit (Kit 042, Bioporto Diagnostics, Hellerup, Denmark). 147 
Samples exceeding the upper limits of the test procedures were diluted according to 148 
the manufacturers’ protocols. 149 
 150 
Immunolabeling 151 
 152 
 Mice were perfusion fixed via the left ventricle with 3% (v/v) paraformaldehyde 153 
in PBS (pH 7.4), where after tissue was post fixed for 1 hour at 4°C. Subsequently, the 154 
tissue was gradually dehydrated in ethanol, incubated in xylene, and embedded in 155 
paraffin. Using a previously described standard protocol (26), paraffin embedded 156 
kidney and colon sections (2 µm) from CNT-KO mice and control mice were labeled 157 
with primary αENaC rabbit antibody (28), dilution 1:800). Paraffin-embedded kidney 158 
sections from the Cre/EGFP reporter mice were labeled with NCC SPC-402D rabbit 159 
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primary antibody (StressMarq Biosciences Inc. Victoria, BC, Canada; dilution 1:200), 160 
calbindin (D28K – 10R-C106A) mouse primary antibody (Fitzgerald Industries 161 
International, Concord, MA, USA; dilution 1:20.000), AQP2 7661 rabbit primary 162 
antibody ((24), dilution 1:1000), and EGFP goat primary antibody (ab6673, Abcam, 163 
Cambridge, UK; dilution 1:1000). For light microscopy, immunolabeling was 164 
visualized using peroxidase-conjugated goat anti-rabbit secondary antibody (p448; 165 
Dako, Glostrup, Denmark; dilution 1:200) and 3,3’-diaminobenzidine (Kem-EN-Tec 166 
Diagnostics A/S, Tåstrup, Danmark). For fluorescence microscopy, immunolabeling 167 
was visualized using the secondary antibodies (dilution 1:600) donkey anti-goat 488 168 
(Molecular Probes, Life Technologies), donkey anti-rabbit 555 (Molecular Probes, Life 169 
Technologies), and donkey anti-mouse 633 (Molecular Probes, Life Technologies). 170 
 171 
Microscopy 172 
 173 
 Counting of αENaC-positive cells in CNT/DCT2 (in cortical labyrinth), and CCD (in 174 
medullary arrays) was performed on kidney sections from CNT-KO mice and control 175 
mice directly in the microscope (400x magnification). Only cells with a distinct 176 
nucleus and apical αENaC labeling were counted. Furthermore, counting was only 177 
performed on cells situated in tubules with a clear visible luminal space and with at 178 
least one αENaC-positive cell in the tubule. The total number of cells counted in the 179 
cortical labyrinth were 345 in the CNT-KO mice (n = 5) and 402 in the control mice (n 180 
= 5). The total number of cells counted in medullary arrays were 86 in the CNT-KO 181 
mice (n = 5) and 70 in the control mice (n = 5). The fraction of αENaC-positive cells 182 
was calculated from the number of αENaC-positive cells divided by the total number 183 
of cells counted in each animal. Imaging of kidney and distal colon sections was 184 
carried out using a Leica DMRE light microscope equipped with a digital camera 185 
(Leica, Wetzlar, Germany). Imaging of kidney and distal colon sections from 186 
Cre/EGFP reporter mice (n = 2) were performed using a Leica TCS SL laser scanning 187 
confocal microscope and Leica confocal software (Leica). Images were merged using 188 
Image J software (Image J, Bethesda, MD, USA). Counting of EGFP-positive cells in the 189 
CNT and DCT2 was performed on confocal images taken from Cre/EGFP mice 190 
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reporter mice, which were labeled for EGFP, calbindin and NCC (n = 2 animals, one 191 
slide from each animal). The images were taken with a 63x objective. The fraction of 192 
EGFP-positive CNT cells (strongly calbindin-positive/NCC-negative) was calculated 193 
from the number of EGFP-positive/strongly calbindin-positive/NCC-negative cells 194 
divided by the total number of strongly calbindin-positive/NCC-negative cells. The 195 
fraction of EGFP-positive DCT2 cells (calbindin- and NCC-positive) was calculated 196 
from the number of EGFP-positive/calbindin- and NCC-positive cells divided by the 197 
total number of calbindin- and NCC-positive cells. The total number of cells counted 198 
in the CNT were 132 (n = 2) and 64 in the DCT2 (n = 2). 199 
 200 
Semi-quantitative immunoblotting 201 
 202 
 Tissue was collected, dissected on ice, and immediately homogenized at 4°C in 203 
dissection buffer containing protease and phosphatase inhibitors. The homogenates 204 
were centrifuged at 1000 g for 10 min at 4°C. The supernatants were supplemented 205 
with sample buffer to a final concentration of 0.1 M SDS and heated to 65° C for 15 206 
min. Samples were run on Criterion™ TGX™ Precast Gels (4–15% or Any kD; Bio-Rad 207 
Laboratories, Hercules, CA, USA) and transferred by electroelution to PVDF 208 
membranes (Bio-Rad Laboratories, Hercules, CA, USA) or Hybond-P PVDF 209 
membranes (GE Healthcare, Little Chalfont, UK). Subsequently, the membranes were 210 
blocked and incubated overnight at 4°C with primary rabbit antibodies [αENaC (30), 211 
dilution 1:1000; NKCC2 1495 (9, 14), dilution 1:50; pT96-T101-NKCC2 9934, (6) 212 
dilution 1:250]; NCC SPC-402D, dilution 1:1000; pT53-NCC 1246 (25), dilution 1:250; 213 
pT58-NCC 1251 (25), dilution 1:1000; or Anti-Kir1.1 (ROMK1) (Alomone, Jerusalem, 214 
Israel; dilution 1:400)]. Labeling was visualized using the Enhanced 215 
Chemiluminescence system (GE Healthcare, Little Chalfont, UK) or SuperSignal West 216 
Femto Chemiluminescent Substrate (Thermo Scientific, Rockford, IL, USA). Because 217 
aldosterone might regulate housekeeping genes such as actin, Coomassie-stained gels 218 
were used to correct quantification for deviations in protein loading. The maximal 219 
deviations in total protein concentration between samples on individual blots were ± 220 
10%.  221 
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Statistical analyses 222 
 223 
 Data meeting statistical assumptions of normality and variance homogeneity were 224 
analyzed using Students two-sided t-test, while data only meeting assumptions of 225 
normality were analyzed using Satterthwaite's two-sided unequal variance t-test. 226 
Data not meeting assumptions of normality were ln-transformed or square-root 227 
transformed in accordance with Sokal and Rohlf (29), and analyzed using the 228 
appropriate t-tests. If data did not fulfill assumptions of normality after 229 
transformation, untransformed data were analyzed using Mann-Whitneys U-test. For 230 
parameters where the CNT-KO mice and control mice were compared at multiple 231 
time points, P-values were adjusted using FDR correction (22). Tests were carried out 232 
using Stata 12.0 (StataCorp, College Station, TX, USA) for Windows. All values are 233 
presented as mean ± SE. 234 
 235 
RESULTS 236 
 237 
Evaluation of CNT-KO mice  238 
 239 
 Breeding of CNT-KO mice and control mice followed Mendelian inheritance (50% 240 
Scnn1alox/lox; Atp6v1b1::Cre and 50% Scnn1alox/lox, n = 204). Using single 241 
immunolabeling, counting of αENaC-positive cells in the cortical labyrinth (no 242 
discrimination was made between CNT and DCT2) identified αENaC expression in 243 
approximately 45% of the cells in the CNT-KO mice, whereas in the control mice the 244 
fraction was approximately 70% (Fig. 1A, B and E). This corresponded to 245 
approximately 40% fewer αENaC-positive cells in the CNT-KO mice (P < 0.001). In the 246 
CCD (medullary arrays), the CNT-KO mice showed a weak tendency towards fewer 247 
αENaC-positive cells (9%; P = 0.217; Fig. 1C, D, and E). The overall lower fraction of 248 
αENaC-positive cells coincided with immunoblotting of cortical/outer medullary 249 
(OM) tissue showing 55% lower total protein intensity of αENaC in the CNT-KO mice 250 
[both cleaved (30 kD) and full length (90 kD), P < 0.001, Fig. 1F and G]. Cre 251 
recombinase activity in the DCT2 was examined by crossing the Atp6v1b1::Cre mice 252 
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with an dsRed/inducible enhanced green fluorescent protein (EGFP) reporter line 253 
(Fig. 2 and 3). The progeny expressed EGFP in only a minor portion of the DCT2 cells 254 
(approximately 6% [5% and 7%, respectively, in the 2 mice], Fig. 2A–C), whereas the 255 
majority of DCT2 cells were EGFP-negative (Fig. 3A–C). This indicated that a potential 256 
deletion of αENaC in the DCT2 was minimal. Consistent with the lower number of 257 
αENaC-positive cells in the CNT-KO, the EGFP reporter mouse expressed EGFP in a 258 
high number of the CNT cells (Fig. 2D–I), while EGFP was absent in the majority of 259 
CCD principal cells (Fig. 2J–L and 3D–F). Cellular counting revealed that 260 
approximately 36% of the CNT cells ([32% and 39%, respectively, in the 2 mice], 261 
identified as strongly calbindin-positive and NCC-negative) expressed EGFP. Thus, 262 
characterization of the mice indicated that αENaC was inactive primarily in a part of 263 
the CNT cells. 264 
 265 
Distal colonic αENaC expression was not impaired in the CNT-KO mice.  266 
 267 
 ENaC is an important mediator of Na+ reabsorption in the surface epithelial layer 268 
of the distal colon (8, 19). It was previously reported that the Atp6v1b1::Cre mice 269 
show unspecific Cre recombinase activity in the colon (20). This could potentially 270 
cause inactivation of αENaC in the distal colon of the CNT-KO mice. The Cre/EGFP 271 
reporter mice showed no detectable EGFP expression in the surface epithelial layer or 272 
in the crypts (Fig. 4A). However, some cells in the connective tissue expressed EGFP 273 
(Fig. 4A, arrows), indicating Cre recombinase activity. We further tested whether 274 
αENaC expression was impaired in the distal colon of the CNT-KO mice by using 275 
immunolabeling and immunoblotting. Immunolabeling detected αENaC in the surface 276 
epithelial layer of both CNT-KO mice and control mice kept on a 4-day 0.01% Na+ diet 277 
(Fig. 4B and C). Immunoblotting demonstrated that the abundance of total αENaC 278 
[(cleaved (30 kD) + full length (90 kD)] did not differ between CNT-KO mice and 279 
control mice kept on the 7-day 0.01% Na+ diet [P = 0.512; Fig.4 and E]. However, the 280 
30 kD/90 kD ratio was higher in the CNT KO mice [P = 0.017, Fig. 4D and E], 281 
suggesting greater cleavage of αENaC and thus, increased activity [reviewed in (27)]. 282 
A non-regulated band was found at 55 kD [CNT-KO mice: 1.00 ± 0.08 (n = 9), control 283 
11 
 
mice: 1.00 ± 0.22 (n = 9), P = 0.986, Fig. 4D and E], but whether this was a cleaved 284 
form of αENaC was not further examined. Collectively, data demonstrated that αENaC 285 
expression was not impaired in the distal colon of the CNT-KO mice. 286 
 287 
Phenotyping of CNT-KO mice on standard and challenging diets.  288 
 289 
 To examine the effect of genetic αENaC inactivation in the CNT on Na+ and K+ 290 
homeostasis, CNT-KO mice and control mice were examined on a standard diet 291 
(baseline), 7-day 0.01% Na+ diet, 4-day 2% K+ diet, a 2-day 5% K+ diet, or a 5% 292 
K+/0.01% Na+ diet. 293 
 294 
Standard diet. When fed a standard diet in regular cages, no differences were found in 295 
plasma [Na+], [K+], creatinine concentration, or osmolality between CNT-KO mice and 296 
control mice (Fig. 5A, B, D and E). However, the plasma aldosterone concentration 297 
was higher in the CNT-KO mice (P < 0.01, Fig. 5C). Baseline measurements in 298 
metabolic cages did not show any differences in the tested parameters [relative body 299 
weight (BW), food intake, water intake, urine output, urine Na+ and K+ output, and 300 
urine osmolality; Fig. 6A–U]. Similarly, no significant differences in these parameters 301 
were observed when pooling baseline data (collected over the last 24 h prior to diet 302 
manipulation) from the metabolic cage experiments (data not shown). 303 
 304 
Seven-day 0.01% Na+ diet. Challenging the CNT-KO mice with a 7-day 0.01% Na+ diet 305 
did not affect plasma [Na+], [K+], creatinine concentration, or osmolality (Fig. 5A, B, D 306 
and E), however, the plasma aldosterone concentration was still higher compared to 307 
the control mice (P < 0.01, day 7, Fig. 5C). On day 3–5, the CNT-KO mice excreted 308 
more Na+ in the urine than the control mice (P between 0.01 and 0.05; Fig. 6E), 309 
however, the difference diminished on day 6 and eventually disappeared on day 7 310 
[not significant (NS), Fig. 6E]. The urine osmolality was higher in the CNT-KO mice on 311 
day 4 and 7 (P < 0.05, Fig. 6G) compared to the control mice, whereas no differences 312 
were found in relative BW, food intake, water intake, urine output, and urine K+ 313 
excretion (Fig. 6A–D and F).  314 
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 315 
Four-day 2% K+ diet. When challenged with a 4-day 2% K+ diet, plasma [Na+], [K+], 316 
creatinine concentration, and osmolality (Fig. 5A, B, and D) did not differ between the 317 
CNT-KO mice and the control mice, however, the plasma aldosterone concentration 318 
was clearly higher (day 4: P < 0.001, Fig. 5C). By contrast, no differences were found 319 
in relative BW, food and water intake, urine output, urine Na+ and K+ output, and 320 
urine osmolality (Fig. 6H–N).  321 
 322 
Two-day 5% K+ diet. The 2-day 5% K+ diet induced a lower relative BW in the CNT-KO 323 
mice compared to the control mice (day 1: P < 0.001; day 2: P < 0.001; Fig. 6O), which 324 
was accompanied by lower plasma [Na+] (day 2: P < 0.001, Fig. 5A). The total urine 325 
Na+ output was unaffected (NS, Fig. 6S), however, the CNT-KO mice consumed less 326 
food (and thereby less Na+) than the control mice (day 1: P < 0.001; day 2: P < 0.01; 327 
Fig. 6P). This was taken into account by calculating the Na+ output (urine)/intake 328 
(food) ratio. The Na+ output/intake ratio was higher in the CNT-KO mice compared to 329 
the control mice on both day 1 (P < 0.001, Table 1) and day 2 (P < 0.01, Table 1). 330 
Furthermore, the fractional excretion (FE) of Na+ was higher in the CNT-KO mice 331 
when measured on day 2 (P < 0.01, Table 1). In terms of K+ homeostasis, the CNT-KO 332 
mice presented higher plasma [K+] (day 2: P < 0.001, Fig. 5B) and lower urine K+ 333 
output (day 1: P < 0.001, day 2: P < 0.05, Fig. 6T) compared to the control mice, but 334 
the K+ output/intake ratio was not different, neither on day 1 nor day 2 (NS, Table 1). 335 
However, the FE of K+ was lower in CNT-KO mice when measured on day 2 (P < 0.05, 336 
Table 1), indicating impaired K+ excretion. Finally, the CNT-KO mice showed higher 337 
plasma aldosterone concentration (day 2: P < 0.001, Fig. 5C), creatinine concentration 338 
(P < 0.01, Table 1), and lower glomerular filtration rate (GFR; P < 0.05, Table 1), water 339 
intake (day 1: P < 0.01, Fig. 6Q), and urine output (day 1: P < 0.05, Fig. 6R) than the 340 
control mice. NGAL concentrations were measured in urine samples collected on day 341 
2. There were no significant differences in urinary NGAL concentrations [CNT-KO 342 
mice: 150.8 ± 52.4 ng/ml (n = 10), control mice: 85.8 ± 35.4 ng/ml (n = 8), P = 0.131] 343 
or in urinary NGAL excretion [CNT-KO mice: 32.0 ± 11.6 ng/g BW/24 h (n = 10), 344 
control mice: 16.6 ± 6.8 ng/g BW/24 h (n = 8), P = 0.248]. 345 
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 Mice were, furthermore, tested on a 2-day 5% K+/0.01% Na+ diet. The control 346 
mice showed lower relative BW both on day 1 (P < 0.001) and day 2 (P < 0.001) 347 
compared to baseline, suggesting that BW loss during K+ loading was not specific for 348 
the CNT-KO mice, but could be induced in control mice when combining K+ loading 349 
and Na+ restriction. However, the weight loss was less severe in the control mice 350 
compared to the CNT-KO both on day 1 (control: 0.96 ± 0.01, n = 10; KO: 0.91 ± 0.00, n 351 
= 10; P < 0.001) and day 2 (control: 0.94 ± 0.01, n = 10; KO: 0.86 ± 0.01, n = 10; P < 352 
0.001).  353 
 354 
The CNT-KO mice presented lower abundance and phosphorylation of NCC on a 5% K+ 355 
diet 356 
 357 
 Hyperkalemia is connected with reduced Na+ reabsorption in the thick ascending 358 
limb (TAL) and the distal convoluted tubule (DCT), leading to increased Na+ delivery 359 
to ENaC-expressing tubular segments thereby favoring K+ secretion (30, 31, 34, 35). 360 
Therefore, we tested whether the higher FE of Na+ in the CNT-KO mice compared to 361 
the control mice during K+ loading occurred in parallel with lower protein abundance 362 
and phosphorylation of the Na+-K+-2Cl- cotransporter, NKCC2 (expressed in TAL), and 363 
the Na+-Cl- cotransporter, NCC (expressed in DCT). Immunoblotting of cortical/OM 364 
tissue (collected on day 2) showed no differences in the protein abundances of 365 
NKCC2, pT96-T101-NKCC2, or the pT96-T101-NKCC2/NKCC2 ratio (NS, Fig. 7). By 366 
contrast, we found a lower abundance of total NCC (P < 0.05, Fig. 7), pT53-NCC (P < 367 
0.01, Fig. 7), and pT58-NCC (P < 0.001, Fig. 7). Furthermore, the pT53-NCC/NCC (P < 368 
0.05, Fig. 7) and the pT58-NCC/NCC ratios (P < 0.001, Fig. 7) were lower in the CNT-369 
KO mice, suggesting that the lower phosphorylation of NCC was not a result of lower 370 
total NCC protein abundance per se. Finally, no effect was found on ROMK abundance 371 
(Fig. 7). Collectively, the higher FE of Na+ in the CNT-KO mice fed a 5% K+ diet 372 
coincided with lower abundance and phosphorylation of NCC in the DCT and lower 373 
αENaC expression in the CNT.  374 
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DISCUSSION  375 
 376 
 This study provides novel insight into the physiological role of αENaC in the 377 
kidney and the activation of compensatory mechanisms in a conditional model of the 378 
PHA-1 syndrome. CNT-KO mice showed a severe phenotype when examined on a 5% 379 
K+ diet as evidenced by e.g. higher plasma [K+] and lower FE of K+. This could be a 380 
result of impaired ENaC-mediated K+ secretion in CNT through apical K+ channels 381 
such as ROMK (2). Although the CNT-KO mice were unable to maintain K+ balance to 382 
the same extent as the controls, data indicated that compensatory mechanisms did 383 
take place. The mice presented higher plasma aldosterone level and lower abundance 384 
and phosphorylation of the DCT-specific Na+ transporter, NCC, indicating lower Na+ 385 
reabsorption in the DCT. Inhibition of Na+ reabsorption in the TAL and the DCT 386 
during hyperkalemia may lead to higher tubular flow rate and Na+ delivery to ENaC-387 
expressing tubule segments (30, 31, 34, 35), producing a favorable gradient for K+ 388 
secretion in the CNT and CCD. Thus, a compensatory target in our model could be 389 
NCC in the DCT. By contrast, we did not observe a significantly lower abundance or 390 
phosphorylation of NKCC2, which is vital for Na+ reabsorption in the TAL and macula 391 
densa. Another potential compensatory target is ROMK, but our data did not show 392 
any changes in ROMK abundance either.  393 
 On the 5% K+ diet, lower NCC activity, together with inactivation of αENaC in the 394 
CNT, coincided with higher FE of Na+ and Na+ output/intake ratio in the CNT-KO mice. 395 
Importantly, this suggests that in the CNT-KO mice, ENaC in the CD was not sufficient 396 
to effectively reabsorb a higher Na+ delivery. Collectively, these events may have 397 
induced the lower plasma [Na+] in the CNT-KO mice. To exclude that the phenotype 398 
could be a result of AKI, urinary NGAL concentrations were determined on day 2. The 399 
lack of differences in both urinary NGAL concentration and excretion as well as the 400 
lack of differences in urine output and water intake between the CNT-KO mice and 401 
the control mice on day 2 indicated that the CNT-KO mice had not developed AKI. We 402 
did not observe any difference in total urinary Na+ output after 1 and 2 days of 5% K+ 403 
loading, however, it cannot be excluded that a potential difference in Na+ output could 404 
be detected at earlier time points (i.e. after minutes) (30). 405 
15 
 
 The CNT-KO mice presented higher aldosterone levels on the low-Na+ diet and a 406 
mild phenotype as evidenced by Na+ wasting on day 3–5. However, this effect 407 
eventually disappeared after 7 days, after which no effects were found on plasma 408 
[Na+] and [K+]. Data indicated higher cleavage of ENaC in the distal colon and this 409 
potential activation of ENaC could, at least partially, have compensated for reduced 410 
renal Na+ reabsorption in the CNT. 411 
 We have previously shown that genetic inactivation of αENaC in the CD did not 412 
interfere with Na+ and K+ balance in mice kept on a standard diet, low-Na+ diet, or a 413 
6% K+ diet (28). This suggests that αENaC in the CD is apparently not a prerequisite 414 
for maintaining Na+ and K+ homeostasis. By contrast, combined αENaC inactivation in 415 
a part of the CNT (approximately 30% fewer αENaC-positive cells in early CNT, and 416 
70% fewer αENaC-positive cells in late CNT) and CD induced PHA-1 symptoms 417 
already on a standard diet as evidenced by natriuresis, hyponatremia, and 418 
hyperkalemia (5). During Na+ restriction, the CNT/CD-KO mice showed lower relative 419 
BW, severe urine Na+ loss, hyponatremia, and hyperkalemia (5). Thus, the phenotype 420 
was stronger in the CNT/CD-KO mice than in the CNT-KO mice on a standard diet or a 421 
low-Na+ diet. Besides a potential compensation in the colon, it is possible that the CD 422 
in the CNT-KO mice could partially compensate for the lack of αENaC in the CNT. 423 
Because αENaC was deleted in the CD of the CNT/CD-KO mice, such compensation 424 
was not possible in these mice. However, it cannot be ruled out either that the 425 
deletion of αENaC in the CNT-KO was less efficient than in the CNT/CD-KO mice 426 
thereby explaining the milder phenotype. Thus, it is possible that the remaining CNT 427 
cells still expressing αENaC in the CNT-KO were sufficient to maintain proper Na+ 428 
balance.  429 
 A 5% K+ diet induced a weaker phenotype in the CNT/CD-KO mice than in the 430 
CNT-KO mice. Both mouse lines showed lower plasma [Na+] and higher plasma [K+] 431 
on the 5% K+ diet, however, the CNT-KO mice additionally presented lower food 432 
intake and lower relative BW, whereas these parameters were unaffected in the 433 
CNT/CD-KO mice. Impaired ENaC-facilitated K+ secretion in the colon (11, 32), was 434 
not likely to cause the stronger phenotype in the CNT-KO mice, because the colonic 435 
αENaC expression was intact. Although the role of ENaC in the DCT2 for K+ secretion 436 
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is unknown, it could be speculated that deletion of αENaC only in a few DCT2 cells 437 
could become critical during K+ loading.  438 
 In summary, we examined the importance of αENaC in the CNT by generating KO 439 
mice in which αENaC was deleted primarily in the CNT. The mice showed no obvious 440 
phenotype on a standard diet, 0.01% Na+ diet, or a 2% K+ diet. The elevated 441 
aldosterone levels in the CNT-KO mice may stimulate ENaC activity in the late CNT (in 442 
remaining ENaC expressing cells), in the CD, or in the colon and potentially 443 
compensate for the reduced Na+ reabsorption in the CNT. On a 5% K+ diet, however, 444 
the mice presented clear PHA-1 symptoms. Our data provide an unprecedented 445 
insight into compensatory mechanisms taking place in a conditional model of the 446 
PHA-1 syndrome. Even when αENaC is deleted only in a part of the CNT, several 447 
compensatory mechanisms occur. During 5% K+ loading, this includes higher plasma 448 
aldosterone level, lower renal NCC activity, and lower GFR. Clinically, the results may 449 
contribute to a deeper understanding of how the body copes with the physiological 450 
challenges that are taking place in PHA-1 patients. 451 
 452 
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FIGURE LEGENDS  603 
 604 
Fig. 1. αENaC expression was lower in the CNT-KO mice. A–D, in mice kept on a 4-day 605 
0.01% Na+ diet, immunolabeling showed more αENaC-positive cells in the CNT/DCT2 606 
(in the cortical labyrinth) of controls (A, arrows indicate αENaC-positive cells) than in 607 
the CNT-KO mice (B, arrow heads indicate αENaC-negative cells). E, the fraction of 608 
αENaC-positive cells in the CNT/DCT2 was approximately 40% lower in the CNT-KO 609 
mice, whereas no significant difference was found in the CCD (C–E, arrows indicate 610 
αENaC-positive cells, in medullary arrays). F and G, on a standard diet, the CNT-KO 611 
mice showed 55% lower total αENaC protein intensity in cortical/outer medullary 612 
tissue homogenate [cleaved (30 kD) + full length (90 kD)]. Each bar indicates mean ± 613 
SE. **P < 0.01, ***P < 0.001.  614 
 615 
Fig. 2. Atp6v1b1::Cre/enhanced green fluorescent protein (EGFP) reporter mice 616 
expressed EGFP in AQP2 and calbindin-positive cells in the CNT, whereas only a few 617 
NCC-positive cells in the DCT2 and a few AQP2-positive cells in the CCD were EGFP 618 
positive. Calbindin was used a marker for CNT/DCT2. A–C, arrow: NCC-619 
positive/EGFP-positive cell. D–F, arrow: calbindin-positive/EGFP-positive cell; 620 
arrowhead: calbindin-negative/EGFP-positive cell; asterisk: calbindin-positive/EGFP-621 
negative cell. G–I, arrow: calbindin-positive/AQP2-positive/EGFP-positive cell; 622 
arrowhead: AQP2-negative/EGFP-positive cell. J–L, arrow: AQP2-positive/EGFP-623 
positive cell; arrowhead: AQP2-negative/EGFP-positive cell; asterisk: AQP2-624 
positive/EGFP-negative cell. Glo: glomerulus. 625 
Fig. 3. The majority of NCC-positive cells in the DCT2 and AQP2-positive cells in the 626 
CCD did not express EGFP in the Atp6v1b1::Cre/EGFP reporter mice. A–C, arrowhead: 627 
NCC-negative/EGFP-positive cell; asterisks: NCC-positive/EGFP-negative cells. D–F, 628 
arrowhead: AQP2-negative/EGFP-positive cell; asterisks: AQP2-positive/EGFP-629 
negative cells. 630 
 631 
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Fig. 4. Distal colonic αENaC expression was not impaired in the CNT-KO mice. A, 632 
Atp6v1b1::Cre/EGFP reporter mice showed EGFP expression in some cells of the 633 
connective tissue in the distal colon (arrows), whereas EGFP was not detectable in 634 
the surface epithelial layer (n = 2). B, in the control mice and C, the CNT-KO mice kept 635 
on a 4-day 0.01% Na+ diet, immunolabeling revealed clear apical labelling in the distal 636 
colonic surface epithelial layer. D and E, immunoblotting and corresponding 637 
densitometric analyses of distal colonic homogenates showed that total αENaC 638 
abundance (30+90 kD bands, arrows) did not differ between the control mice and the 639 
CNT-KO mice kept on a 7-day 0.01% Na+ diet. The 30/90 kD-ratio was, however, 640 
higher in the CNT-KO mice than in the control mice. Each bar indicates mean ± SE. *P 641 
< 0.05. LU: lumen, CR: crypt. 642 
 643 
Fig. 5. Blood parameters: the CNT-KO mice presented a clear phenotype on a 5% K+ 644 
diet. Effects of various diets on, A, plasma [Na+], B, plasma [K+], C, plasma aldosterone 645 
concentration, D, plasma creatinine concentration, and, E, plasma osmolality in the 646 
control mice and the CNT-KO mice. The mice were kept on either a standard diet in 647 
regular cages ([Na+], [K+], creatinine and osmolality: control n = 7, KO n = 9; 648 
aldosterone: control n = 14, KO n = 17), 7-day 0.01% Na+ diet in metabolic cages 649 
([Na+], [K+], aldosterone, and osmolality: control n = 17, KO n = 18; creatinine: control 650 
n = 15, KO n = 15), 4-day 2% K+ diet in metabolic cages (control n = 9, KO n = 9), or a 651 
2-day 5% K+ diet in metabolic cages (control n = 8, KO n = 10). Each bar indicates 652 
mean ± SE. **P < 0.01, ***P < 0.001.  653 
 654 
Fig. 6. Metabolic parameters: the CNT-KO mice presented a clear phenotype on a 5% 655 
K+ diet. The control mice and the CNT-KO mice were kept in metabolic cages on a 656 
standard diet (baseline) followed by either a, A–G, 7-day 0.01% Na+ diet (control n = 657 
17–18, KO n = 17–18), H–N, 4-day 2% K+ diet (control n = 9, KO n = 9), or, O–U, a 2-658 
day 5% K+ diet (O–R, control n = 17, KO n = 18; S–U, control n = 9, KO n = 8). Each 659 
circle indicates mean ± SE. *P < 0.05, **P < 0.01, ***P < 0.001. 660 
 661 
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Fig. 7. The CNT-KO mice presented lower abundance and phosphorylation of NCC on 662 
a 5% K+ diet. Presented are protein abundances of NKCC2, p-NKCC2 (pT96/T101), 663 
NCC, pT53-NCC, pT58-NCC, and ROMK in control mice (n = 8) and CNT-KO mice (n = 664 
10) as determined by immunoblotting of cortical/outer medullary tissue 665 
homogenates. Furthermore, presented are the ratios of pT96-T101-NKCC2/NKCC2, 666 
pT53-NCC/NCC, and pT58-NCC/NCC. Each bar indicates mean ± SE. *P < 0.05, **P < 667 
0.01, ***P < 0.001. 668 
  669 
28 
 
TABLES 670 
 
Table 1. Urine and plasma parameters in control mice and CNT-KO mice kept on a 
2-day 5% K+ diet  
Parameter Control KO P Mean SE n Mean SE n 
Na+ output/intake ratio  Baseline 0.73 0.07 9 0.71 0.06 8 NS 
day 1 0.98 0.05 9 1.47 0.07 8 < 0.001 
day 2 0.72 0.04 9 0.95 0.05 8 < 0.01 
K+ output/intake ratio  Baseline 0.72 0.05 9  0.66 0.06 8 NS 
 day 1 0.73 0.03 9  0.60 0.04 8 NS 
 day 2 0.69 0.03 9  0.70 0.04 8 NS 
FE Na+ (%) day 2 0.42 0.03 8 0.56 0.03 10 < 0.01 
FE K+ (%) day 2 71 7 8 51 5 10 < 0.05 
Plasma creatinine (mM) day 2 7.6 0.4 8 11.0 0.7 10 < 0.01 
GFR (µl/min) day 2 290 30 8 219 17 10 < 0.05 
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